特发性肺纤维化患者生活问卷的研制与初步验证
研究在美国FDA药物开发工具资格认定流程下,通过焦点小组、概念 elicitation 和认知 debriefing 访谈开发含44条的试点问卷,并迁移为电子版在125例IPF患者中开展14天纵向研究。经心理测量学检验后保留35条,形成症状和影响两个模块的L-IPF问卷,含五个量表,信效度良好,与同期FVC%预计值相关并能区分不同疾病严重程度。
要点
- L-IPF问卷含症状和影响两个模块共35条,产生五个量表。
- 问卷心理测量学性质良好,与同期FVC%预计值相关。
- 问卷能区分不同IPF严重程度的患者。
核心结论
- L-IPF是评估IPF患者症状、疾病影响和健康相关生活质量的新问卷,初步验证显示心理测量学性质良好。
研究设计与样本
- 通过FDA药物开发工具资格认定流程,经焦点小组、概念 elicitation 和认知 debriefing 访谈开发44条试点问卷。
- 试点问卷迁移为电子版,在125例IPF患者中开展14天纵向研究进行现场测试。
主要发现
- 125例IPF患者中62.4%为男性,平均±SD年龄69±7.60岁,平均FVC%预计值71±20.0。
- 经因子和条目分析后保留35条,构成L-IPF问卷的症状和影响两个模块。
- L-IPF产生五个量表,心理测量学性质良好,与同期收集的FVC%预计值相关,并能区分不同IPF严重程度的患者。
临床怎么用
- L-IPF可用于IPF患者症状、疾病影响和健康相关生活质量的评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Several new drugs for idiopathic pulmonary fibrosis (IPF) are in development. Tools are needed to assess whether these drugs benefit patients on outcomes that matter most to them. Health-related quality of life (HRQL) is one such outcome. It is influenced by many factors, but symptoms and their impacts are two strong drivers.Objectives: To develop a questionnaire to assess symptoms, disease impacts, and HRQL specifically for patients with IPF.Methods: Working with the U.S. Food and Drug Administration through the Drug Development Tool Qualification process, focus groups, concept elicitation, and cognitive debriefing interviews were conducted to inform the development of a 44-item pilot questionnaire. The pilot paper-and-pen questionnaire was migrated to an equivalent electronic version and field-tested in a 14-day study. Response data were subjected to psychometric testing, including exploratory factor analysis, item calibration using item response theory models, test-retest reliability, and validity testing.Measurements and Main Results: A total of 125 patients with IPF (62.4% men) completed the longitudinal study. The mean ± SD age of the cohort was 69 ± 7.60 years, and the mean FVC% predicted was 71 ± 20.0. After factor and item analyses, 35 items were retained, and these comprise the two modules (symptoms and impacts) of the Living with IPF (L-IPF) questionnaire. The L-IPF yields five scales demonstrating good psychometric properties, including correlation with concurrently collected FVC% predicted and the ability to discriminate between patients with differing levels of IPF severity.Conclusions: The L-IPF is a new questionnaire that assesses symptoms, disease impacts, and HRQL in patients with IPF.
引用
- Swigris JJ, Andrae DA, Churney T, et al. Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire. Am J Respir Crit Care Med. 2020. PMID: 32634038. doi:10.1164/rccm.202002-0415OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。